Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Other Income (Expense) : ¥18 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co Other Income (Expense)?

Beijing Aosaikang Pharmaceutical Co's other income expense for the Beijing Aosaikang Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ¥5 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥18 Mil.

Beijing Aosaikang Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Beijing Aosaikang Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Aosaikang Pharmaceutical Co Other Income (Expense) Chart

Beijing Aosaikang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

45.01

29.24

11.54

47.95

19.97

Beijing Aosaikang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															7.30	6.50	1.84	4.33	5.05

Beijing Aosaikang Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥18 Mil.

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Beijing Aosaikang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » Other Income (Expense)

Traded in Other Exchanges

N/A

Address

South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070

Website

http://www.bnec.cn

Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.

Executives

Wang Zheng Yong	Executives
Li Xiao Xin	Supervisors
Ren Wei Rong	Directors, executives
Chen Qing Cai	Directors, Directors, and Executives
Du Chao Yang	Executives
Ma Yao Chuan	Director
Wu Zhan Feng	Supervisors
Guo Hong Jie	Director

Beijing Aosaikang Pharmaceutical Co Headlines

No Headlines